117 related articles for article (PubMed ID: 31493216)
1. Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers.
Furuie H; Kanda H
Clin Drug Investig; 2019 Dec; 39(12):1185-1194. PubMed ID: 31493216
[TBL] [Abstract][Full Text] [Related]
2. Comparison of recombinant and plasma-derived antithrombin biodistribution in a rabbit model.
Berry LR; Thong B; Chan AK
Thromb Haemost; 2009 Aug; 102(2):302-8. PubMed ID: 19652880
[TBL] [Abstract][Full Text] [Related]
3. Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapy.
Paidas MJ; Forsyth C; Quéré I; Rodger M; Frieling JT; Tait RC;
Blood Coagul Fibrinolysis; 2014 Jul; 25(5):444-50. PubMed ID: 24686101
[TBL] [Abstract][Full Text] [Related]
4. Bioequivalence of two intravenous formulations of antithrombin III: a two-way crossover study in healthy Korean subjects.
Kim KA; Lim YY; Kim SH; Park JY
Clin Ther; 2013 Nov; 35(11):1752-61. PubMed ID: 24094463
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human antithrombin expressed in the milk of non-transgenic goats exhibits high efficiency on rat DIC model.
Yang H; Li QW; Han ZS; Hu JH; Li WY; Liu ZB
J Thromb Thrombolysis; 2009 Nov; 28(4):449-57. PubMed ID: 19455283
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic, tolerability, and bioequivalence comparison of three different intravenous formulations of recombinant human erythropoietin in healthy Korean adult male volunteers: an open-label, randomized-sequence, three-treatment, three-way crossover study.
Cho SH; Lim HS; Ghim JL; Choe S; Kim UJ; Jung JA; Bae KS
Clin Ther; 2009 May; 31(5):1046-53. PubMed ID: 19539105
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology and clinical applications of human recombinant antithrombin.
Pal N; Kertai MD; Lakshminarasimhachar A; Avidan MS
Expert Opin Biol Ther; 2010 Jul; 10(7):1155-68. PubMed ID: 20528611
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data.
Paidas MJ; Triche EW; James AH; DeSancho M; Robinson C; Lazarchick J; Ornaghi S; Frieling J
Am J Perinatol; 2016 Mar; 33(4):343-9. PubMed ID: 26461927
[TBL] [Abstract][Full Text] [Related]
9. Management of Heparin-Resistant Patients with Benefits? Maximizing Biocompatibility in Cardiopulmonary Bypass: Combining ATryn® Recombinant Antithrombin III and Carmeda® Heparin-Bonded Perfusion Circuits: A Case Series.
Chryssos A; Stroup SJ; Pifer MM; Tawil M; Conrad CG
J Extra Corpor Technol; 2015 Mar; 47(1):44-7. PubMed ID: 26390679
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term administration of high-dose recombinant human antithrombin in immunosuppressed primate recipients of porcine xenografts.
Cozzi E; Simioni P; Boldrin M; Seveso M; Calabrese F; Baldan N; Busetto R; Tormene D; Gavasso S; Castagnaro M; Echelard Y; Rice T; Plebani M; Carraro P; Bosio E; Valente M; Pagnan A; Thiene G; Ancona E
Transplantation; 2005 Nov; 80(10):1501-10. PubMed ID: 16340797
[TBL] [Abstract][Full Text] [Related]
11. A new fully human recombinant FSH (follitropin epsilon): two phase I randomized placebo and comparator-controlled pharmacokinetic and pharmacodynamic trials.
Abd-Elaziz K; Duijkers I; Stöckl L; Dietrich B; Klipping C; Eckert K; Goletz S
Hum Reprod; 2017 Aug; 32(8):1639-1647. PubMed ID: 28591833
[TBL] [Abstract][Full Text] [Related]
12. A phase III, double-blind, placebo-controlled, multicenter study on the efficacy of recombinant human antithrombin in heparin-resistant patients scheduled to undergo cardiac surgery necessitating cardiopulmonary bypass.
Avidan MS; Levy JH; Scholz J; Delphin E; Rosseel PM; Howie MB; Gratz I; Bush CR; Skubas N; Aldea GS; Licina M; Bonfiglio LJ; Kajdasz DK; Ott E; Despotis GJ
Anesthesiology; 2005 Feb; 102(2):276-84. PubMed ID: 15681940
[TBL] [Abstract][Full Text] [Related]
13. Efficient single step chromatographic purification of recombinant human antithrombin (rhAT) from Saccharomyces cerevisiae.
Mallu MR; Vemula S; Ronda SR
3 Biotech; 2016 Jun; 6(1):112. PubMed ID: 28330182
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulant and anti-inflammatory effects after peritoneal lavage with antithrombin in experimental polymicrobial peritonitis.
van Veen SQ; Cheung CW; Meijers JC; van Gulik TM; Boermeester MA
J Thromb Haemost; 2006 Nov; 4(11):2343-51. PubMed ID: 16911675
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection.
Togawa A; Tanaka T; Nagashima S; Keta H; Kobayashi Y; Nishikawa Y; Yanai M; Tanaka H
Br J Clin Pharmacol; 2004 Sep; 58(3):269-76. PubMed ID: 15327586
[TBL] [Abstract][Full Text] [Related]
16. An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome.
Endo S; Shimazaki R;
J Intensive Care; 2018; 6():75. PubMed ID: 30473794
[TBL] [Abstract][Full Text] [Related]
17. A Comparison of the Oligosaccharide Structures of Antithrombin Derived from Plasma and Recombinant Using POTELLIGENT
Yagi Y; Okazaki A; Endo M; Yanagisawa K; Fukuda J; Nishimura K; Yamazaki K
Anal Sci; 2019 Dec; 35(12):1333-1340. PubMed ID: 31423004
[TBL] [Abstract][Full Text] [Related]
18. Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin.
Edmunds T; Van Patten SM; Pollock J; Hanson E; Bernasconi R; Higgins E; Manavalan P; Ziomek C; Meade H; McPherson JM; Cole ES
Blood; 1998 Jun; 91(12):4561-71. PubMed ID: 9616152
[TBL] [Abstract][Full Text] [Related]
19. A randomized phase 3 trial evaluating antithrombin gamma treatment in Japanese patients with early-onset severe preeclampsia (KOUNO-TORI study): Study protocol.
Saito S; Takagi K; Moriya J; Kobayashi T; Kanayama N; Sameshima H; Morikawa M; Sago H; Adachi T; Ohkuchi A; Takeda S; Masuyama H; Seki H
Contemp Clin Trials; 2021 Aug; 107():106490. PubMed ID: 34174463
[TBL] [Abstract][Full Text] [Related]
20. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
Bittner B; Riek M; Holmes B; Grange S
Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
